Thyroid Cancer

The thyroid gland lies in the front of the neck, just below the larynx and directly in front of the trachea (windpipe). This important endocrine ("hormone") gland takes up iodine from the blood stream and produces "thyroxine," a hormone very important to many body functions.

The thyroid has two lobes that sit on either side of the trachea, joined by a small "isthmus." It is made up of two distinct types of cells. The so-called "follicular cells" produce the thyroid hormone, while the "C" cells make a chemical called "calcitonin," which helps to regulate calcium within the body.

The normal thyroid is barely palpable, but "goiter," (generalized swelling most often caused by iron deficiency), or tumor growth may lead to a palpable or visible lump in the neck.

   

Cancers of the Thyroid

There are four distinct types of thyroid cancer:

  • Papillary carcinoma- this develops from follicular cells and grows quite slowly. It is usually found in only one lobe (side) of the gland
  • Follicular carcinoma- this develops from follicular cells, too,but is less common than papillary. It also grows slowly.
    (Papillary and follicular cancers make up nearly 90% of all thyroid cancers.)
  • Medullary carcinoma- this develops in C cells, often as part of a syndrome called "multiple endocrine neoplasia."
  • Anaplastic carcinoma- this is a rare, poorly differentiated and fast-growing tumor that develops from other, better differentiated tumors. The speed of its growth makes it difficult to treat.

Risks factors for thyroid cancer include:

  • Family history- goiters in the family increase risk for papillary cancer; medullary cancer in the family increases the medullary cancer risk
  • Radiation exposure- Pre-1950 low-dose radiation treatments for acne or tonsillitis; radiation treatments for Hodgkin or non-Hodgkin lymphoma in the head an neck
  • Diet low in iodine
  • Gender- women get more thyroid cancer than men
  • Ethnicity- Caucasians get more thyroid cancer than blacks

Symptoms are varied, and may include:

  • A lump in the front of the neck
  • Hoarseness
  • Trouble swallowing
  • Pain in the throat or neck
  • Swollen glands in the neck
  • Persistent cough

The diagnostic process begins with a thorough physical exam. Palpation of the neck for any anatomical distortions or masses is particularly important. The doctor will also check some blood tests to measure the level of thyroid hormone and of "thyroid stimulating hormone" (from the pituitary). He may also check calcitonin levels. Ultrasound tests help to distinguish between hollow "cysts" in the gland and solid tumors, while radionuclide scanning will separate functioning ("hot") nodules from non-functioning, "cold" nodules (the latter more likely to be cancerous).

Often, the head an neck surgeon can obtain some cells from a thyroid mass by using a "fine needle aspiration" right in the office. After numbing the area with local anesthetic, he can insert of tiny needle into several parts of the mass to sample cells for the cytologic pathologist. When this sort of test is inconclusive, the surgeon may recommend open biopsy or removal of the nodule-containing lobe under general anesthesia.

Staging

TNM is an abbreviation for tumor (T), node (N), and metastasis (M). Doctors look at these three factors to determine the stage of cancer.

T0: There is no evidence of a tumor.
T1: The tumor is 1 cm or less and limited to the thyroid.
T2: The tumor is at least 1 cm, but not more than 4 cm, and is limited to the thyroid.
T3: The tumor is larger than 4 cm, but does not extend beyond the thyroid.
T4: The tumor is any size and has extended beyond the thyroid.

The "N" in the TNM system stands for lymph nodes, the small, bean-shaped organs that help fight infection.

N0: There is no evidence of cancer in the lymph nodes.
N1a: Cancer has spread to lymph nodes in the neck on the same side as the tumor.
N1b: Cancer has spread to lymph nodes on both sides of the neck, the opposite side, the middle of the neck or the chest (mediastinal).


The "M" in the TNM system describes cancer that has spread to other parts of the body.


MX: distant metastasis cannot be evaluated.
M0: cancer has not spread to other parts of the body.
M1: cancer has spread to other parts of the body.

Stages using TNM

(Papillary or follicular tumors in those under age 45)

Stage I: a tumor (T) with no spread to lymph nodes (N0) and no distant metastasis (M0).

Stage II: a tumor (T) with any metastasis (M1) regardless of whether it has spread to the lymph nodes (N).

Stage III: any invasive tumor (T4) with no spread to lymph nodes (N0) or metastasis (M0), or any tumor (T) that has spread to the lymph nodes (N1).

Stage IV: This stage describes all tumors when there is metastasis (M1).

(Papillary or follicular tumors in those over age 45)

Stage I: a tumor (T) with no spread to lymph nodes (N0) and no distant metastasis (M0).

Stage II: any larger, noninvasive tumor (T2, T3) with no spread to lymph nodes (N0) and no metastasis (M0).

Stage III: any invasive tumor (T4) with no spread to lymph nodes (N0) or metastasis (M0), or any tumor (T) that has spread to the lymph nodes (N1).

Stage IV: This stage describes all tumors when there is metastasis (M1).

(Medullary carcinomas)

Stage I: a small tumor (T1) with no spread to lymph nodes (N0) and no distant metastasis (M0).

Stage II: any tumor (T) with no spread to lymph nodes (N0) and no metastasis (M0).

Stage III: any tumor (T) that has spread to lymph nodes (N1), but has not metastasized (M0).

Stage IV: evidence of metastasis (M1). All undifferentiated anaplastic thyroid tumors are stage IV

Treatment

A number of modalities have place in the treatment of thyroid cancers. Surgery, hormonal treatments, radioactive iodine therapy,radiation and chemotherapy are all used, depending upon the size and location of the tumor and the patient's general health.

Surgery is the main treatment in most cases. Depending upon the tumor type and size, the head and neck surgeon may remove the lobe containing the nodule ("lobectomy"), or the entire thyroid ("total thyroidectomy"). If there is reason to suspect lymph node involvement, the surgeon will also perform a "neck dissection" to remove the nodes. When the entire gland is removed, the body will no longer produce thyroid hormone. Therefore, doctors will place the patient on hormone replacement with a pill.

Four tiny glands called "parathyroid" are located on the back of the thyroid. They are very important to calcium metabolism. Although the surgeon will try to leave at least one gland in place when performing thyroidectomy, this is not always possible. If they are all lost or function poorly, the patient will be placed on calcium supplements and vitamin D after surgery.

Because the thyroid gland soaks up virtually all of the body's iodine, radioactive iodine is quickly concentrated in any thyroid tissues after administration by doctors. The radiation produced by this helps to destroy any cancerous thyroid cells not removed by surgery. Radioactive iodine is used for many with papillary and follicular cancers, but not for the other tissue types. If the cancer has spread beyond the surgical site, pain and swelling may occur wherever the metastatic cells are located. Because the salivary glands also concentrate iodine, patients may experience swelling of these glands and dry mouth for a time.

Those treated surgically for papillary, follicular and medullary cancers will require thyroid hormone therapy after surgery. This serves a dual purpose: it replaces the hormone that they can no longer produce, and it slows the growth of any cancer cells that may remain. This latter effect only relates to differentiated cancers.

External radiation therapy uses high-energy x-rays to kill cells. The treatment is usually given five days a week for about five to six weeks either in a hospital or outpatient facility. Radiation therapy is used only for patients with advanced thyroid cancer that has not responded to radioiodine therapy. Radiation therapy may be given after completion of surgery.

Although chemotherapy has a role in the treatment of some thyroid cancers, its use is determined on an individual basis and is most often administered as part of a clinical trial (research study).